<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04261036</url>
  </required_header>
  <id_info>
    <org_study_id>OGY.TB.09/BIO-2017-0609</org_study_id>
    <nct_id>NCT04261036</nct_id>
  </id_info>
  <brief_title>Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries</brief_title>
  <official_title>Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Study Protocol for a Randomized Double Blinded Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This open-label randomized trial aims at assessing the role of Vitamin C pills in the
      prevention of catheter-associated urinary tract infections in women undergoing elective
      gynecological surgeries.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Vitamin C and Placebo pills will be blindly labeled and assorted in opaque containers in the Pharmacy department according to a computer generated list that allocated random assignment of vitamin C or placebo to a 200 positions (serial numbers from 1 to 200).
The research assistant in charge of the recuitment will not be aware of the content of each opaque container and would be providing them to patients according to the order in which they are recruited starting with container number 1, then 2 and so on.
The primary care provider and the investigators are blinded as well as they are not aware of the assignment of each recruited patient to placebo vs interventional arm.
It is only upon completion of data collection that results would be compared with the randomized generated list in order to link the recruited patients and their collected data with their original assignment to placebo vs intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants who experienced clinically diagnosed and treated UTI.</measure>
    <time_frame>14 days</time_frame>
    <description>Urinary tract infection is diagnosed by a positive urine culture.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants with asymptomatic bacteruria</measure>
    <time_frame>14 days</time_frame>
    <description>Participants with positive urine culture but no symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Catheter-Associated Urinary Tract Infection, Ascorbic Acid</condition>
  <arm_group>
    <arm_group_label>Women on a vitamin C regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women who are undergoing elective gynecological surgeries and who are randomized to take 1g of vitamin C for 14 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women on a placebo regimen</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women who are undergoing elective gynecological surgeries and who are randomized to take placebo for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ascorbic Acid 1000 mg</intervention_name>
    <description>1000 mg ascorbic acid (Vitamin C) for 14 days post-op after an elective gynecological surgery.</description>
    <arm_group_label>Women on a vitamin C regimen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo pills for 14 days post-op after an elective gynecological surgery.</description>
    <arm_group_label>Women on a placebo regimen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or
             the OBGYN floor (7N), presenting for elective GYN surgery at the American University
             of Beirut Medical Center (AUBMC).

        Exclusion Criteria:

          -  Any women with the following:

               1. Nephrolithiasis

               2. Congenital anomaly or neurogenic bladder

               3. Allergy to ascorbic acid

               4. Who require therapeutic anticoagulant medicine during the 6 weeks after surgery

               5. Surgery did involve a fistula repair or a vaginal mesh removal

               6. Positive Urinalysis in the PAU

               7. Recurrent UTI's

               8. Diabetes

               9. G6PD

              10. Hemochromatosis

              11. Renal disorders

        Patients already taking Vitamin C supplementation will also be excluded from the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tony Bazi, MD</last_name>
    <phone>9611350000</phone>
    <email>tb04@aub.edu.lb</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Omar Z Baba, MD</last_name>
    <phone>9613596474</phone>
    <email>ob07@aub.edu.lb</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony Bazi, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <reference>
    <citation>Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015 Aug;213(2):194.e1-8. doi: 10.1016/j.ajog.2015.04.003. Epub 2015 Apr 13.</citation>
    <PMID>25882919</PMID>
  </reference>
  <reference>
    <citation>Ochoa-Brust GJ, Fernández AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernández B, Vásquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86(7):783-7.</citation>
    <PMID>17611821</PMID>
  </reference>
  <reference>
    <citation>Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide. 2001 Dec;5(6):580-6.</citation>
    <PMID>11730365</PMID>
  </reference>
  <reference>
    <citation>Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med. 2004 Apr 26;164(8):842-50. Review.</citation>
    <PMID>15111369</PMID>
  </reference>
  <reference>
    <citation>Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011 Jan 1;52(1):23-30. doi: 10.1093/cid/ciq073.</citation>
    <PMID>21148516</PMID>
  </reference>
  <reference>
    <citation>Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013;15(2):41-8.</citation>
    <PMID>24082842</PMID>
  </reference>
  <reference>
    <citation>Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg. 2008 Jun;143(6):551-7. doi: 10.1001/archsurg.143.6.551.</citation>
    <PMID>18559747</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 6, 2020</study_first_submitted>
  <study_first_submitted_qc>February 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 6, 2020</last_update_submitted>
  <last_update_submitted_qc>February 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>American University of Beirut Medical Center</investigator_affiliation>
    <investigator_full_name>Tony Bazi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Vitamin C, CAUTI, Ascorbic Acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

